Recognition and management of masked hypertension: a review and novel approach.

Published

Journal Article (Review)

Failure to show benefit in some cardiovascular and renal outcome trials may be a consequence of masked hypertension, a blood pressure in the hypertensive range outside the office setting. Ambulatory blood pressure monitoring and home blood pressures obtained by the patient are superior to office blood pressure for assessing individual target-organ damage and predicting cardiovascular disease morbidity and mortality. Lastly, masked hypertension is associated with an increased risk of developing primary hypertension and can be treated with either short-acting medications or improvement of underlying causes. We review the clinical impact of masked hypertension on cardiovascular risk and progression of kidney disease. We further propose a clinical management paradigm specific for masked hypertension that needs confirmation in a clinical trial.

Full Text

Duke Authors

Cited Authors

  • Yano, Y; Bakris, GL

Published Date

  • May 2013

Published In

Volume / Issue

  • 7 / 3

Start / End Page

  • 244 - 252

PubMed ID

  • 23523411

Pubmed Central ID

  • 23523411

Electronic International Standard Serial Number (EISSN)

  • 1878-7436

Digital Object Identifier (DOI)

  • 10.1016/j.jash.2013.02.002

Language

  • eng

Conference Location

  • United States